Divergent SARS-CoV-2 Omicron–reactive T and B cell responses in COVID-19 vaccine recipients
Corine H. GeurtsvanKessel(Erasmus University Rotterdam), Rory D. de Vries(Erasmus MC)
Cited by 438
Related Papers
SARS-CoV-2 variants of concern partially escape humoral but not T cell responses in COVID-19 convalescent donors and vaccine recipients
|Science Immunology|2021|591
Clearance of influenza virus from the lung depends on migratory langerin+CD11b− but not plasmacytoid dendritic cells
|The Journal of Experimental Medicine|2008|465
High-titer convalescent plasma plus nirmatrelvir/ritonavir treatment for non-resolving COVID-19 in six immunocompromised patients
|Journal of Antimicrobial Chemotherapy|2023|23
Clinical and Virological Outcome of Monoclonal Antibody Therapies Across SARS-CoV-2 Variants in 245 Immunocompromised Patients: A Multicenter Prospective Cohort Study
|Clinical Infectious Diseases|2024|15
Potential determinants of the decline in mpox cases in Belgium: A behavioral, epidemiological and seroprevalence study
|International Journal of Infectious Diseases|2024|8